Circio Holding ASA is a clinical stage company developing immune activators to target difficult-to-treat diseases. The company’s mission is to deploy vector-based technology to create a novel class of targeted, multi-functional circRNA medicines. It has established a cutting-edge circular RNA (circRNA) program and is collaborating with Prof Michael Uhlin and a team at the Karolinska Institutet in Stockholm with the intent to develop next generation RNA therapeutics for various applications. The company also has a mutant RAS cancer vaccine program, with two collaborative clinical trials underway in the USA and Norway. It is currently looking at options for the financing of a phase 2 study for ONCOS-102, a genetically modified oncolytic adenovirus.
View Top Employees from Circio Holding ASA| Website | http://www.circio.com |
| Employees | 22 (10 on RocketReach) |
| Founded | 2010 |
| Industry | Biotechnology Research |
Looking for a particular Circio Holding ASA employee's phone or email?
Circio Holding ASA Questions
Lubor Gaal is the CFO of Circio Holding ASA.
10 people are employed at Circio Holding ASA.
Top Circio Holding ASA Employees
-
43
-
1
Related Companies
